Neogenix Oncology Inc
SEC CIK 1341293 · None · last insider filing 2013-02-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Arlen Myron | Director · Director of Medical Affairs | filed 2010 - 2013 |
| Arlen Philip | Director · President and CEO | filed 2010 - 2013 |
| Holladay J Douglas | Director | filed 2010 - 2010 |
| Shriver Timothy P | Director | filed 2010 - 2010 |
| Krominga Lynn | Director | filed 2010 - 2010 |
| Gordon Peter | Director · CFO and Secretary | filed 2010 - 2010 |
| Feldman James | Director | filed 2010 - 2010 |
| Greene Dennis | Director | filed 2010 - 2010 |
| Gause Barry | Director | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Martin Albine | Chief Operating Officer | filed 2011 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.